[Venlafaxine-containing prolonged release: critical exchange?].
Saussele
Tanja
T
D018687:Antidepressive Agents, Second-Generation / Q000008:administration & dosage* / Q000493:pharmacokinetics; D003511:Cyclohexanols / Q000008:administration & dosage* / Q000493:pharmacokinetics; D003692:Delayed-Action Preparations; D017277:Drug Approval; D016568:Drugs, Generic; D005858:Germany; D006801:Humans; D013810:Therapeutic Equivalency; D000069470:Venlafaxine Hydrochloride
D018687:Antidepressive Agents, Second-Generation; D003511:Cyclohexanols; D003692:Delayed-Action Preparations; D016568:Drugs, Generic; D000069470:Venlafaxine Hydrochloride